#KidneyWk on X 1 day ago

Promising results of the VALIANT trial of pegcetacoplan for C3G/IC-MPGN were presented at #KidneyWk. #kidneydisease #nephrology https://t.co/X9KTTR...

View Post

#KidneyWk on X 2 days ago

RT @kidney_boy: Dietary potassium acts like a thiazide diuretic. Wow. That explains a lot. #KidneyWk https://t.co/FfiqYg9lSu

View Post

#KidneyWk on X 2 days ago

RT @rc_oncneph: A young trainee @ASNKidney #KidneyWk asks: what do onconephs do? IMO not always about identifying a novel renal toxicity…

View Post

#KidneyWk on X Friday, November 29 @ 4:30 AM

Final results of the IGNAZ study presented at #KidneyWk showed felzartamab led to sustained proteinuria reduction and reduced eGFR decline in IgAN....

View Post

#KidneyWk on X Friday, November 29 @ 1:56 AM

RT @VHIR_: 📌Un estudi internacional amb participació de @vallhebron mostra que el fàrmac semaglutida, per a l'obesitat i la diabetis, prote…

View Post

#KidneyWk on X Friday, November 29 @ 1:56 AM

RT @incliva_iis: 🗞️ Un estudio internacional en el que participa INCLIVA muestra que el fármaco Semaglutida, para la diabetes y la obesidad…

View Post

#KidneyWk on X Friday, November 29 @ 12:56 AM

RT @Medfyle1: Stay updated on IgA nephropathy with NEW expert podcast episodes from our ASN #KidneyWk Conference Coverage. Listen now: http…

View Post

#KidneyWk on X Friday, November 29 @ 12:56 AM

Stay updated on IgA nephropathy with NEW expert podcast episodes from our ASN #KidneyWk Conference Coverage. Listen now: https://t.co/OaE5DLCZkV #...

View Post

#KidneyWk on X Thursday, November 28 @ 11:15 AM

RT @brendonneuen: Identifying people with lower UACR who remain at high risk of CKD progression could facilitate more efficient & inclusiv…

View Post

#KidneyWk on X Thursday, November 28 @ 11:00 AM

RT @inozyme: Today, we presented positive interim data from our Phase 1 SEAPORT 1 trial of our lead program, INZ-701, in patients with end-…

View Post